Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Painful limbs/moving extremities.

S Papapetropoulos1, A A Argyriou

  • 1Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. spapapetropoulos@med.miami.edu

Acta Neurologica Scandinavica
|October 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.

Journal of neurology·2022
Same author

Drug repurposing from the perspective of pharmaceutical companies.

British journal of pharmacology·2017
Same author

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

European journal of cancer (Oxford, England : 1990)·2013
Same author

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.

European journal of neurology·2012
Same author

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

Painful limbs/moving extremities (PLME) causes slow, involuntary toe and finger movements, often with pain. Research is ongoing to understand its causes and improve treatments like nerve blocks and botulinum toxin.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Painful limbs/moving extremities (PLME) is a neurological disorder.
  • Characterized by slow, involuntary toe/finger movements, often painful.
  • Etiopathogenesis remains unknown; treatments are empirical.

Purpose of the Study:

  • To summarize the current understanding of PLME.
  • To highlight knowledge gaps in its etiopathogenesis.
  • To suggest future research directions.

Main Methods:

  • Review of existing literature on PLME.
  • Discussion of current treatment strategies.
  • Exploration of proposed pathophysiological mechanisms.

Main Results:

  • PLME involves spontaneous, slow (1-2 Hz) involuntary movements.

Related Experiment Videos

  • Associated with CNS/PNS diseases or idiopathic.
  • Nerve blocks, botulinum toxin, and oral medications show some success.

    • Conclusions:

    • PLME requires further investigation into its underlying mechanisms.
    • Future research should focus on electrophysiology, imaging, and clinical trials.
    • Refined therapeutic strategies are needed for effective PLME management.